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Case Report
Allergic Contact Dermatitis to
Mastisol Adhesive Used for Skin
Closure in Orthopedic Surgery: A
Case Report
Abstract
We report on a rare case of allergic contact dermatitis (ACD)
from Mastisol liquid adhesive. We are aware of a few reports in
the medical literature, but none describes an allergic reaction
during the third exposure to the offending agent. Our patient
was a 20-year-old Caucasian man with a history of cerebral
palsy spastic hemiplegia who underwent single-event
multilevel soft-tissue surgery to optimize function of his left
upper extremity. He developed a severe cutaneous allergic
reaction after his third exposure to Mastisol. He was
subsequently admitted to the inpatient service and managed
without further complications by a multidisciplinary team
comprising orthopedics, pediatrics, and dermatology. We
discuss the etiology, clinical features, diagnosis, and treatment
of this entity, and we also review relevant available literature on
the subject. We aim at creating further awareness of allergic
reactions because of exposure to available skin-prepping and
wound-dressing agents.
This case discusses a rare incidenceof an allergic contact dermatitis
(ACD) after exposure to Mastisol
adhesive in a surgical setting. There
is a dearth of reports in the medical
literature describing previous in-
stances. The process of skin prepara-
tion and wound closure are key steps
in ensuring uncomplicated postoper-
ative wound healing. Our case report
describes a complication after the use
of a wound adhesive to optimize the
surgical incision healing. Prompt rec-
ognition and management is impor-
tant to limit further complications.
ACD is an underrecognized and un-
common cause of readmission in the
postoperative period in orthopedic
surgery.
Case Presentation
A 20-year-old man with a history of
cerebral palsy, obsessive compulsive
disorder, and allergies to sulfa and
gluten presented to our clinic with
severe itching of his left upper extrem-
ity (Figure 1). Four days before, he
underwent multilevel soft-tissue sur-
gery at the elbow, forearm, and wrist
to address myostatic contractures
with a goal to optimize function. At
the start of the surgery, the skin was
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prepped with ChloraPrep (chlorhexi-
dine gluconate). At the end of the
surgery, a two-layer closure of the
surgical incision was done using 2-0
polyglactin 910 (Vicryl) for subcuta-
neous approximation and 3-0 poly-
glecaprone 25 (Monocryl) for skin
closure. The superficial wound edges
were approximated with 3M-Steri-
Strips after applying Mastisol liquid
adhesive. The wound was covered
with Xeroform petrolatum-coated
gauze, sterile gauze, and a fiberglass
long arm cast. Our patient had an
unremarkable postoperative course
and was discharged the next day to
home with a follow-up appointment
in two weeks for cast check. He
presented 4 days later to the clinic
with complaints of intense itching
under the cast that started the day
after discharge from hospital, with
his mother noting attempts by the
patient to excoriate the skin under
the cast when at home. The cast and
wound dressings were removed to
reveal large tense fluid-filled bullae
and smaller vesicles with yellow
crust superimposed on red edematous
plaques along and surrounding the
surgical incision sites (see Figure 1).
The patient was afebrile and otherwise
medically stable with no concerning
constitutional signs or symptoms, but
he did complain of significant pruri-
tus. A suspicion for ACD to Mastisol
was made, with cellulitis and erysipe-
las as potential differential diagnoses.
The dermatology team was promptly
involved in the subsequent care for
this patient. They confirmed the di-
agnosis of acute ACD to Mastisol
given the linearity along the incision
line with an acute blistering and
dermatitic eruption. Inpatient hos-
pital admission ensued for manage-
ment of his symptoms and severe
contact dermatitis as well as to
monitor for potential signs of infec-
tion and wound dehiscence.
On admission, the wounds were
dressed with clobetasol propionate
0.05% ointment and Mepilex Trans-
fer dressing (soft silicone–faced poly-
urethane wound contact layer) coated
in petroleum jelly, followed by a soft
conform gauze overwrap and static
splint, twice daily. Itching was con-
trolled with hydroxyzine every 8
hours. Because of the severity of the
eruption, once daily oral prednisone
(60 mg) starting on day of admission
was initiated for a 5-day course.
Antimicrobial coverage was provided
with oral cephalexin 500 mg every 12
hours for a total of 10 days. The
postoperative orthopedic plan was
modified from using a long arm cast
to a removable wrist hand orthosis to
allow for frequent wound inspections
and dressing changes. The patient
was discharged home 2 days later
with instructions for wound-dressing
change twice daily and subsequent
follow-up in the orthopedics clinic.
The patient was seen in clinic after
approximately three weeks during
which all signs of contact dermatitis
had resolved with minor residual
erythema as expected at 3 weeks post-
op (see Figure 1). Regular follow-up
Figure 1
A, Left wrist dorsal—4 days post surgery (top) and 21 days post surgery (bottom). B, Left cubital fossa—4 days post
surgery (top) and 21 days post surgery (bottom). C, Left wrist volar—4 days post surgery (top) and 21 days post surgery
(bottom).
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visits in the orthopedics clinic ensued
without further complicating events.
Discussion
Allergic contact dermatitis (ACD)
is a type IV delayed (cell-mediated)
hypersensitivity reaction (an excep-
tion to other “allergic” reactions that
are predominantly type I hypersen-
sitivity reactions). It requires previ-
ous contact with an offending agent
or a chemically similar compound.
Once an individual has been sensi-
tized, a subsequent contact with the
same or chemically similar allergen
can trigger a reaction at the original
site of sensitization. Typically, ACD is
present as erythema, edema, dermati-
tis, and blistering of the affected area.
Certain clinical indicators such as the
delineation and often geographic
configuration of the skin eruption,
pruritus, timing of symptoms, and
lack of tenderness support the diag-
nosis of ACD.
The linear pattern of the bullous
cutaneous eruption in our patient en-
compassed only the area where the
liquid adhesive was applied along the
wound closure sites. This observation,
coupled with the experience of the
dermatology team and the paucity
of allergic reactions secondary to the
other used products in this case such
as Xeroform or Steri-Strips in the
medical literature, helped to narrow
down our hitherto short list of the
potential offending agents. We were
able to discount chlorhexidine as a
potential cause because it was used
beyond the site of allergic reaction.
Mastisol (Ferndale Laboratories) is a
liquid adhesive for securing wound
dressings and tapes. It is available in
single-use vials, 15-mL and 2-oz. bot-
tles, and a 15-mL spray bottle. It con-
tains gum resin, styrax liquid, methyl
salicylate, and alcohol (SDA 23A).
Styrax is a shrub that produces the
storax resin (also an ingredient in
tincture of benzoin). Gum resin (also
known as colophony) is a natural
resin from thePistacia lentiscus tree.1
Mastisol has been reported to have
about seven to eight times more
adhesiveness, as well as a lower inci-
dence of postoperative contact der-
matitis, compared with the previously
favored adhesive Compound Tincture
of Benzoin (CTB)2. Colophony has
been reported to have a 2% cutaneous
allergen ACD reaction rate with patch
testing (Hood et al3).
The incidence of Mastisol-induced
ACD is unknownbecauseof paucity of
previous studies in the medical litera-
ture. A literature search carried out
in September 2017 on MEDLINE,
CINAHL, Web of Science, EMBASE,
and Scopus databases using keywords
“mastisol,” “gum mastic,” and “der-
matitis” as combined search criteria
resulted in a limited set of previously
published cases. The summary of our
findings is presented in Table 1.
Our patient had two previous ex-
posures (2 and 7 years earlier) to
Mastisol with no documented history
of adverse reactions.Antigenic-induced
primary sensitization is an unusual
event predominantly expressed 7 to
10 days after exposure in a previously
unsensitized individual and 12 to 48
hours after exposure in a patient with a
history of previous sensitization.4 In
this case, it is unlikely that our patient
was sensitized to Mastisol during
his first encounter with it because he
had no reaction during the second
encounter. It is important for patients
and caregivers to recognize that ACD
can also occur at any time, even after
many exposures to an allergen over
many months to years.
Diagnosis
Diagnosis of ACD is clinical. A typical
case could present as a peri-incisional
erythema along with signs of derma-
titis and blistering seen 5 to 14 days
after surgery during which a wound
adhesive was used for incision clo-
sure.5 The co-presentation of sys-
temic symptoms such as fever, chills,
and incision site pain or purulent
drainage should prompt a compre-
hensive workup for an infectious
etiology. Some reports (Kline6) have
suggested patch testing before actual
surgery to identify high-risk patients.
This suggestion presents its own set of
challenges with cost implications and
time commitment for testing and
interpretation, before surgery date. In
addition, a similar case as ours may
have posed difficult to prevent,
considering that our patient was
exposed to the causative substance
during the last two surgeries without
any adverse reactions and would not
have been considered a high-risk
patient.
Table 1
Summary of Literature Review
Lead Author (Year) Highlight of Case Reports
Mabrie et al8 Mastisol-induced contact dermatitis after a
rhinoplasty procedure.
Kline6 A patient with ACD at the incision site one day
after a foot surgery that involved skin prep using
DuraPrep and skin closure using Steri-Strips
and Mastisol. The patch test compared Steri-
Strips, Mastisol, and DuraPrep and showed
significant reaction to Mastisol skin adhesive.
Caldwell et al9 ACD in a patient exposed to Mastisol for
intrathecal pump placement, which resolved
within a week on topical steroids.
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Treatment
A multidisciplinary treatment ap-
proach that encompasses the knowl-
edge and expertise of orthopedics,
dermatology subspecialties, andwound
care specialists is needed to manage the
patient.Treatmentplans should include
diligentwound care, anti-inflammatory
agents including topical corticosteroids
and oral steroids when indicated, and
oral antihistamines for pruritus relief.
Careful monitoring for potential sec-
ondarywound infectionanddehiscence
should be undertaken, and superficial
wound cultures should be done if there
is concern for infection.
This case is unique because ACD is a
rare complication of orthopedic sur-
gery and has not been reported previ-
ously as a cause of readmission within
30 days of surgery. This becomes even
more relevant because the 30-day
postoperative readmission rate is be-
ing used as a quality health outcomes
indicator. Thibaudeau et al7 in their
retrospective analysis of the 2013
National Surgery Quality Improve-
ment Program pediatric database
identified surgical site infection, frac-
ture, pneumonia, and cellulitis as
some of the leading causes of read-
mission within 30 days of upper
extremity surgery, with no mention
made of allergic reaction to wound
dressings or other topical prepara-
tions used in the perioperative period
(Thibaudeau et al7).
In this case, the ACD also necessi-
tated a change in the postoperative
orthopedic protocol to allow for its
appropriate treatment without com-
promising the goals of surgery. We
changed our original plan from a long
arm cast to a static splint andnighttime
elbow extension splint to allow for
twice daily wound-dressing changes
which eventually worked well for the
care team and the family on discharge.
Conclusions
Incidences ofACD toMastisol are rare
or possibly underreported. Our case
portrays amoderate-to-severe instance
of this localized reaction. Early recog-
nition and treatment with a multidis-
ciplinary approach is key to managing
patients effectively without adversely
jeopardizing wound healing and func-
tional outcomes.
Keypoints
1. ACD as a result of wound-
dressing material may be rare,
but can occur. A high index of
suspicion is needed for prompt
diagnosis.
2. ACD can be recognized based on
its geographic pattern that tends
to correspond to the location of
the placement of the offending
agent, as well as the typical
clinical appearance of vesicles,
bullae, and acute dermatitis.
Early recognition is important to
prevent further complications
and misdiagnosis.
3. The successful management of
ACD often requires a multi-
disciplinary approach including
surgery, dermatology, and med-
icine specialties.
References
1. Worsnop F, Affleck A, Varma S, English J:
Allergic contact dermatitis from Mastisol
mistaken for cellulitis. Contact Dermatitis
2007;56:357–358.
2. Lesesne CB: Postoperative use of wound
adhesives: Gum mastic versus benzoin, USP.
J Dermatol Surg Oncol 1992;18:990.
3. Hood CR, Cornell RS, Greenfield B: Liquid
adhesive contact dermatitis after
bunionectomy: A case report and literature
review. J Foot Ankle Surg 2016;55:209-214.
4. Filiatrault A, Camasta C: Postoperative
allergic contact dermatitis to tincture of
benzoin and gum mastic. Podiatric Case Rep
Podiatry Inst 2003 Chapter 3, Page 14-17.
5. Durando D, Porubsky C,Winter S, Kalymon J,
O’Keefe T, LaFond AA: Allergic contact
dermatitis to dermabond (2-octyl
cyanoacrylate) after total knee arthroplasty.
Dermatitis 2014;25:99-100.
6. Kline A: Allergic contact dermatitis of the
foot after use of Mastisol skin adhesive: A
case report. Foot Ankle J Volume 2008;1:2.
7. Thibaudeau S, Anari JB, Carducci N,
Carrigan RB: 30-day readmission after
pediatric upper extremity surgery: Analysis
of the NSQIP database. J Pediatr Surg 2016;
51:1370-1374.
8. Mabrie DC, Papel ID: An unexpected
occurrence of acute contact dermatitis during
rhinoplasty. Arch Facial Plast Surg 1999;1:
320-321.
9. Caldwell M, Walega D: Mastisol induced
allergic contact dermatitis. J Pain 2012;13;
S26.
Adhesive Used for Skin Closure
4 Journal of the American Academy of Orthopaedic Surgeons
